Top

Reviews in Endocrine and Metabolic Disorders

01-03-2024 | Obesity

A multifaceted and inclusive methodology for the detection of sarcopenia in patients undergoing bariatric surgery: an in-depth analysis of current evidence

Authors: Eunhye Seo, Yeongkeun Kwon, Ahmad ALRomi, Mohannad Eledreesi, Sungsoo Park

Published in: Reviews in Endocrine and Metabolic Disorders

Abstract

Bariatric surgery is widely recognized as the most effective intervention for obesity and offers benefits beyond weight loss. However, not all patients achieve satisfactory weight loss, balanced changes in body composition, and resolution of comorbidities. Therefore, thorough pre- and postoperative evaluations are important to predict success and minimize adverse effects. More comprehensive assessments require broadening the focus beyond body weight and fat measurements to consider quantitative and qualitative evaluations of muscles. Introducing the concept of sarcopenia is useful for assessing the degradative and pathological changes in muscles associated with cardiometabolic function, physical performance, and other obesity-related comorbidities in patients undergoing bariatric surgery. However, there is currently no consensus or definition regarding the research and clinical use of sarcopenia in patients undergoing bariatric surgery. Therefore, this review aimed to define the concept of sarcopenia applicable to patients undergoing bariatric surgery, based on the consensus reached for sarcopenia in the general population. We also discuss the methods and significance of measuring muscle mass, quality, and strength, which are key variables requiring a comprehensive assessment.

Available only for authorised users

Cosentino C, Marchetti C, Monami M, Mannucci E, Cresci B. Efficacy and effects of bariatric Surgery in the treatment of obesity: network meta-analysis of randomized controlled trials. Nutr Metab Cardiovasc Dis. 2021;31:2815–24. https://doi.org/10.1016/j.numecd.2021.06.018.CrossRefPubMed

Andersson DP, Dahlman I, Eriksson Hogling D, Bäckdahl J, Toft E, Qvisth V, Näslund E, Thorell A, Rydén M, Arner P. Improved metabolism and body composition beyond normal levels following gastric bypass Surgery: a longitudinal study. J Intern Med. 2019;285:92–101. https://doi.org/10.1111/joim.12824.CrossRefPubMed

Adams TD, Davidson LE, Litwin SE, Kim J, Kolotkin RL, Nanjee MN, Gutierrez JM, Frogley SJ, Ibele AR, Brinton EA, Hopkins PN, McKinlay R, Simper SC, Hunt SC. Weight and metabolic outcomes 12 years after gastric bypass. N Engl J Med. 2017;377:1143–55. https://doi.org/10.1056/NEJMoa1700459.CrossRefPubMedPubMedCentral

van de Laar AW, van Rijswijk AS, Kakar H, Bruin SC. Sensitivity and specificity of 50% excess weight loss (50% EWL) and twelve other bariatric criteria for weight loss success. Obes Surg. 2018;28:2297–304. https://doi.org/10.1007/s11695-018-3173-4.CrossRefPubMed

Grover BT, Morell MC, Kothari SN, Borgert AJ, Kallies KJ, Baker MT. Defining weight loss after bariatric Surgery: a call for standardization. Obes Surg. 2019;29:3493–9. https://doi.org/10.1007/s11695-019-04022-z.CrossRefPubMed

Gómez-Ambrosi J, Andrada P, Valentí V, Rotellar F, Silva C, Catalán V, Rodríguez A, Ramírez B, Moncada R, Escalada J, Salvador J, Frühbeck G. Dissociation of body mass index, excess weight loss and body fat percentage trajectories after 3 years of gastric bypass: relationship with metabolic outcomes. Int J Obes (Lond). 2017;41:1379–87. https://doi.org/10.1038/ijo.2017.134.CrossRefPubMed

Gómez-Ambrosi J, Silva C, Galofré JC, Escalada J, Santos S, Millán D, Vila N, Ibañez P, Gil MJ, Valentí V, Rotellar F, Ramírez B, Salvador J, Frühbeck G. Body mass index classification misses subjects with increased cardiometabolic risk factors related to elevated adiposity. Int J Obes (Lond). 2012;36:286–94. https://doi.org/10.1038/ijo.2011.100.CrossRefPubMed

Tabesh MR, Abolhasani M, Zali MR, Bagheri R, Alipour M, Cheraghloo N, Asadzadeh-Aghdaei H, Wong A, Zahedi H, Hobaby S, Shadnoush M, Cheraghpour M. The impact of bariatric Surgery procedures on the modulation of cardiometabolic risk factors in patients with severe obesity: a 12-month follow-up. J Int Med Res. 2022;50:3000605221119657. https://doi.org/10.1177/03000605221119657.CrossRefPubMed

Haghighat N, Ashtary-Larky D, Bagheri R, Aghakhani L, Asbaghi O, Amini M, Moeinvaziri N, Hosseini B, Wong A, Shamekhi Z, Jafarian F, Hosseini SV. Preservation of fat-free mass in the first year after bariatric Surgery: a systematic review and meta-analysis of 122 studies and 10,758 participants. Surg Obes Relat Dis. 2022;18:964–82. https://doi.org/10.1016/j.soard.2022.02.022.CrossRefPubMed

10.

Nuijten MAH, Eijsvogels TMH, Monpellier VM, Janssen IMC, Hazebroek EJ, Hopman MTE. The magnitude and progress of lean body mass, fat-free mass, and skeletal muscle mass loss following bariatric Surgery: a systematic review and meta-analysis. Obes Rev. 2022;23:e13370. https://doi.org/10.1111/obr.13370.CrossRefPubMed

11.

Prado CM, Wells JC, Smith SR, Stephan BC, Siervo M. Sarcopenic obesity: a critical appraisal of the current evidence. Clin Nutr. 2012;31:583–601. https://doi.org/10.1016/j.clnu.2012.06.010.CrossRefPubMed

12.

Maïmoun L, Aouinti S, Puech M, Lefebvre P, Deloze M, de Santa Barbara P, Renard E, Christol JP, Myzia J, Picot MC, Mariano-Goulart D, Nocca D. Changes in lean tissue mass, Fat Mass, biological parameters and resting energy expenditure over 24 months following sleeve gastrectomy. Nutrients. 2023;15. https://doi.org/10.3390/nu15051201.

13.

Holanda N, Crispim N, Carlos I, Moura T, Nóbrega E, Bandeira F. Musculoskeletal effects of obesity and bariatric Surgery - a narrative review. Arch Endocrinol Metab. 2022;66:621–32. https://doi.org/10.20945/2359-3997000000551.CrossRefPubMedPubMedCentral

14.

Wolfe RR. The underappreciated role of muscle in health and Disease. Am J Clin Nutr. 2006;84:475–82. https://doi.org/10.1093/ajcn/84.3.475.CrossRefPubMed

15.

Bužga M, Pekar M, Uchytil J, Horká V, Malůš J, Vilímek D, Švagera Z, Kutáč P, Holéczy P. Prevention of Sarcopenia in patients with obesity after bariatric and metabolic Surgery: the effect of programmed training on the muscle tissue and anthropometric functions - a randomized controlled trial (SarxOb study protocol). Bosn J Basic Med Sci. 2022. https://doi.org/10.17305/bjbms.2022.7786.CrossRef

16.

Pekař M, Pekařová A, Bužga M, Holéczy P, Soltes M. The risk of Sarcopenia 24 months after bariatric Surgery - assessment by dual energy X-ray absorptiometry (DEXA): a prospective study. Wideochir Inne Tech Maloinwazyjne. 2020;15:583–7. https://doi.org/10.5114/wiitm.2020.93463.CrossRefPubMedPubMedCentral

17.

Rosenberg IH. Sarcopenia: origins and clinical relevance. J Nutr. 1997. https://doi.org/10.1093/jn/127.5.990S. 127;Suppl:990S–1S.

18.

Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, Cooper C, Landi F, Rolland Y, Sayer AA, Schneider SM, Sieber CC, Topinkova E, Vandewoude M, Visser M, Zamboni M. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48:16–31. https://doi.org/10.1093/ageing/afy169.CrossRefPubMed

19.

Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, Topinková E, Vandewoude M, Zamboni M. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older people. Age Ageing. 2010;39:412–23. https://doi.org/10.1093/ageing/afq034.CrossRefPubMedPubMedCentral

20.

Barazzoni R, Bischoff SC, Boirie Y, Busetto L, Cederholm T, Dicker D, Toplak H, Van Gossum A, Yumuk V, Vettor R. Sarcopenic obesity: time to meet the challenge. Clin Nutr. 2018;37:1787–93. https://doi.org/10.1016/j.clnu.2018.04.018.CrossRefPubMed

21.

Donini LM, Busetto L, Bischoff SC, Cederholm T, Ballesteros-Pomar MD, Batsis JA, Bauer JM, Boirie Y, Cruz-Jentoft AJ, Dicker D, Frara S, Frühbeck G, Genton L, Gepner Y, Giustina A, Gonzalez MC, Han HS, Heymsfield SB, Higashiguchi T, Laviano A, Lenzi A, Nyulasi I, Parrinello E, Poggiogalle E, Prado CM, Salvador J, Rolland Y, Santini F, Serlie MJ, Shi H, Sieber CC, Siervo M, Vettor R, Villareal DT, Volkert D, Yu J, Zamboni M, Barazzoni R. Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement. Obes Facts. 2022;15:321–35. https://doi.org/10.1159/000521241.CrossRefPubMedPubMedCentral

22.

Ji T, Li Y, Ma L. Sarcopenic obesity: an emerging public health problem. Aging Dis. 2022;13:379–88. https://doi.org/10.14336/AD.2021.1006.CrossRefPubMedPubMedCentral

23.

Mastino D, Robert M, Betry C, Laville M, Gouillat C, Disse E. Bariatric Surgery outcomes in sarcopenic obesity. Obes Surg. 2016;26:2355–62. https://doi.org/10.1007/s11695-016-2102-7.CrossRefPubMed

24.

Voican CS, Lebrun A, Maitre S, Lainas P, Lamouri K, Njike-Nakseu M, Gaillard M, Tranchart H, Balian A, Dagher I, Perlemuter G, Naveau S. Predictive score of Sarcopenia occurrence one year after bariatric Surgery in severely obese patients. PLoS ONE. 2018;13:e0197248. https://doi.org/10.1371/journal.pone.0197248.CrossRefPubMedPubMedCentral

25.

Molero J, Moizé V, Flores L, De Hollanda A, Jiménez A, Vidal J. The impact of age on the prevalence of sarcopenic obesity in bariatric Surgery candidates. Obes Surg. 2020;30:2158–64. https://doi.org/10.1007/s11695-019-04198-4.CrossRefPubMed

26.

Simó-Servat A, Ibarra M, Libran M, Rodríguez S, Perea V, Quirós C, Orois A, Pérez N, Simó R, Barahona M-J. Usefulness of muscle ultrasound to study sarcopenic obesity: a pilot case-control study. J Clin Med. 2022;11:2886. https://doi.org/10.3390/jcm11102886.CrossRefPubMedPubMedCentral

27.

Coral RV, Bigolin AV, Machry MC, Menguer RK, Pereira-Lima JC, Contin I, Stock PV. Improvement in muscle strength and metabolic parameters despite muscle mass loss in the initial six months after bariatric Surgery. Obes Surg. 2021;31:4485–91. https://doi.org/10.1007/s11695-021-05634-0.CrossRefPubMed

28.

Ruthes EMP, Lenardt BCC, Lass AD, Petroski CA, de Mello MF, de Andrade Junior AB, Souza CJF, de Matos O, Castelo-Branco C. Lean mass and strength profile of women submitted to bariatric Surgery: comparison of the EWGSOP2 and FNIH classification for Sarcopenia - ASBS program phase II. Gynecol Endocrinol. 2022;38:868–73. https://doi.org/10.1080/09513590.2022.2119956.CrossRefPubMed

29.

Vieira FT, Godziuk K, Lamarca F, Melendez-Araújo MS, Lima RM, Prado CM, de Carvalho KMB, Dutra ES. Sarcopenic obesity diagnosis by different criteria mid-to long-term post-bariatric Surgery. Clin Nutr. 2022;41:1932–41. https://doi.org/10.1016/j.clnu.2022.07.006.CrossRefPubMed

30.

Baad VMA, Bezerra LR, de Holanda NCP, Dos Santos ACO, da Silva AAM, Bandeira F, Cavalcante TCF. Body composition, Sarcopenia and physical performance after bariatric Surgery: differences between sleeve gastrectomy and Roux-en-Y gastric bypass. Obes Surg. 2022;32:3830–8. https://doi.org/10.1007/s11695-022-06335-y.CrossRefPubMed

31.

Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, Jatoi A, Loprinzi C, MacDonald N, Mantovani G, Davis M, Muscaritoli M, Ottery F, Radbruch L, Ravasco P, Walsh D, Wilcock A, Kaasa S, Baracos VE. Definition and classification of cancer Cachexia: an international consensus. Lancet Oncol. 2011;12:489–95. https://doi.org/10.1016/S1470-2045(10)70218-7.CrossRefPubMed

32.

Prado CM, Lieffers JR, McCargar LJ, Reiman T, Sawyer MB, Martin L, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol. 2008;9:629–35. https://doi.org/10.1016/S1470-2045(08)70153-0.CrossRefPubMed

33.

Gaillard M, Tranchart H, Maitre S, Perlemuter G, Lainas P, Dagher I. Preoperative detection of sarcopenic obesity helps to predict the occurrence of gastric leak after sleeve gastrectomy. Obes Surg. 2018;28:2379–85. https://doi.org/10.1007/s11695-018-3169-0.CrossRefPubMed

34.

Vassilev G, Galata C, Finze A, Weiss C, Otto M, Reissfelder C, Blank S. Sarcopenia after Roux-en-Y gastric bypass: detection by skeletal muscle mass index versus bioelectrical impedance analysis. J Clin Med. 2022;11. https://doi.org/10.3390/jcm11061468.

35.

Beaudart C, McCloskey E, Bruyère O, Cesari M, Rolland Y, Rizzoli R, Araujo de Carvalho I, Amuthavalli Thiyagarajan J, Bautmans I, Bertière MC, Brandi ML, Al-Daghri NM, Burlet N, Cavalier E, Cerreta F, Cherubini A, Fielding R, Gielen E, Landi F, Petermans J, Reginster JY, Visser M, Kanis J, Cooper C. Sarcopenia in daily practice: assessment and management. BMC Geriatr. 2016;16:170. https://doi.org/10.1186/s12877-016-0349-4.CrossRefPubMedPubMedCentral

36.

Gonzalez MC, Heymsfield SB. Bioelectrical impedance analysis for diagnosing Sarcopenia and cachexia: what are we really estimating? J Cachexia Sarcopenia Muscle. 2017;8:187–9. https://doi.org/10.1002/jcsm.12159.CrossRefPubMedPubMedCentral

37.

Yamada Y, Nishizawa M, Uchiyama T, Kasahara Y, Shindo M, Miyachi M, Tanaka S. Developing and validating an age-independent equation using multi-frequency bioelectrical impedance analysis for estimation of appendicular skeletal muscle mass and establishing a cutoff for Sarcopenia. Int J Environ Res Public Health. 2017;14. https://doi.org/10.3390/ijerph14070809.

38.

Bianchi L, Maietti E, Abete P, Bellelli G, Bo M, Cherubini A, Corica F, Di Bari M, Maggio M, Martone AM, Rizzo MR, Rossi AP, Volpato S, Landi F. Comparing EWGSOP2 and FNIH sarcopenia definitions: agreement and 3-year survival prognostic value in older hospitalized adults: the GLISTEN study. J Gerontol A Biol Sci Med Sci. 2020;75:1331–7. https://doi.org/10.1093/gerona/glz249.CrossRefPubMed

39.

Setiati S. Diagnostic tools for Sarcopenia: can we get less expensive and accurate methods? Acta Med Indones. 2019;51:93–4.PubMed

40.

Simó-Servat A, Ibarra M, Libran M, et al. Usefulness of Ultrasound in assessing the impact of bariatric Surgery on body composition: a pilot study. Obes Surg. 2023;33:1211–7. https://doi.org/10.1007/s11695-023-06510-9.CrossRefPubMedPubMedCentral

41.

Mirón Mombiela R, Vucetic J, Rossi F, Tagliafico AS. Ultrasound biomarkers for Sarcopenia: what can we tell so far? Semin Musculoskelet Radiol. 2020;24:181–93. https://doi.org/10.1055/s-0039-3402745.CrossRefPubMed

42.

Watanabe Y, Yamada Y, Fukumoto Y, et al. Echo intensity obtained from ultrasonography images reflecting muscle strength in elderly men. Clin Interv Aging. 2013;8:993–8. https://doi.org/10.2147/cia.S47263.CrossRefPubMedPubMedCentral

43.

Ivanoski S, Vasilevska Nikodinovska V. Future ultrasound biomarkers for Sarcopenia: Elastography, contrast-enhanced Ultrasound, and speed of Sound Ultrasound Imaging. Semin Musculoskelet Radiol. 2020;24:194–200. https://doi.org/10.1055/s-0040-1701630.CrossRefPubMed

44.

Gallagher D, Visser M, De Meersman RE, Sepúlveda D, Baumgartner RN, Pierson RN, Harris T, Heymsfield SB. Appendicular skeletal muscle mass: effects of age, gender, and ethnicity. J Appl Physiol (1985). 1997;83:229–39. https://doi.org/10.1152/jappl.1997.83.1.229.CrossRefPubMed

45.

Lee SH, Gong HS. Measurement and interpretation of handgrip strength for research on Sarcopenia and osteoporosis. J Bone Metab. 2020;27:85–96. https://doi.org/10.11005/jbm.2020.27.2.85.CrossRefPubMedPubMedCentral

46.

Marcos-Pardo PJ, González-Gálvez N, Carbonell-Baeza A, Jiménez-Pavón D, Vaquero-Cristóbal R. GDLAM and SPPB batteries for screening Sarcopenia in community-dwelling Spanish older adults: healthy-age network study. Exp Gerontol. 2023;172:112044. https://doi.org/10.1016/j.exger.2022.112044.CrossRefPubMed

47.

Studenski SA, Peters KW, Alley DE, Cawthon PM, McLean RR, Harris TB, Ferrucci L, Guralnik JM, Fragala MS, Kenny AM, Kiel DP, Kritchevsky SB, Shardell MD, Dam TT, Vassileva MT. The FNIH Sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci. 2014;69:547–58. https://doi.org/10.1093/gerona/glu010.CrossRefPubMedPubMedCentral

48.

Heo JE, Kim HC, Shim JS, Song BM, Bae HY, Lee HJ, Suh I. Association of appendicular skeletal muscle mass with carotid intima-media thickness according to body mass index in Korean adults. Epidemiol Health. 2018;40:e2018049. https://doi.org/10.4178/epih.e2018049.CrossRefPubMedPubMedCentral

49.

Haines MS, Leong A, Porneala BC, Meigs JB, Miller KK. Association between muscle mass and Diabetes prevalence Independent of body fat distribution in adults under 50 years old. Nutr Diabetes. 2022;12:29. https://doi.org/10.1038/s41387-022-00204-4.CrossRefPubMedPubMedCentral

50.

Newman AB, Kupelian V, Visser M, Simonsick E, Goodpaster B, Nevitt M, Kritchevsky SB, Tylavsky FA, Rubin SM, Harris TB. Sarcopenia: alternative definitions and associations with lower extremity function. J Am Geriatr Soc. 2003;51:1602–9. https://doi.org/10.1046/j.1532-5415.2003.51534.x.CrossRefPubMed

51.

Vincent HK, Mathews A. Obesity and mobility in advancing age: mechanisms and interventions to preserve Independent mobility. Curr Obes Rep. 2013;2:275–83. https://doi.org/10.1007/s13679-013-0059-6.CrossRef

52.

Alalwan AA, Friedman J, Park H, Segal R, Brumback BA, Hartzema AG. US national trends in bariatric Surgery: a decade of study. Surgery. 2021;170:13–7. https://doi.org/10.1016/j.surg.2021.02.002.CrossRefPubMed

53.

Reinmann A, Gafner SC, Hilfiker R, Bruyneel AV, Pataky Z, Allet L. Bariatric Surgery: consequences on functional capacities in patients with obesity. Front Endocrinol (Lausanne). 2021;12:646283. https://doi.org/10.3389/fendo.2021.646283.CrossRefPubMed

54.

Baad VMA, Bezerra LR, de Holanda NCP, et al. Body composition, Sarcopenia and physical performance after bariatric Surgery: differences between Sleeve Gastrectomy and Roux-En-Y gastric bypass. Obes Surg. 2022;32:3830–8. https://doi.org/10.1007/s11695-022-06335-y.CrossRefPubMed

55.

Vaurs C, Diméglio C, Charras L, Anduze Y, Chalret du Rieu M, Ritz P. Determinants of changes in muscle mass after bariatric Surgery. Diabetes Metab. 2015;41:416–21. https://doi.org/10.1016/j.diabet.2015.04.003.CrossRefPubMed

56.

Ciudin A, Simó-Servat A, Palmas F, Barahona MJ. Sarcopenic obesity: a new challenge in the clinical practice. Endocrinol Diabetes Nutr (Engl Ed). 2020;67:672–81. https://doi.org/10.1016/j.endinu.2020.03.004.CrossRefPubMed

57.

Shishikura K, Tanimoto K, Sakai S, Tanimoto Y, Terasaki J, Hanafusa T. Association between skeletal muscle mass and insulin secretion in patients with type 2 Diabetes Mellitus. Endocr J. 2014;61:281–7. https://doi.org/10.1507/endocrj.ej13-0375.CrossRefPubMed

58.

Ghachem A, Lagacé JC, Brochu M, Dionne IJ. Fat-free mass and glucose homeostasis: is greater fat-free mass an Independent predictor of insulin resistance? Aging Clin Exp Res. 2019;31:447–54. https://doi.org/10.1007/s40520-018-0993-y.CrossRefPubMed

59.

Zaniqueli D, de Oliveira Alvim R, Griep RH, Benseñor IM, Barreto SM, Lotufo PA, Mill JG. Insulin resistance may be misdiagnosed by HOMA-IR in adults with greater fat-free mass: the ELSA-Brasil Study. Acta Diabetol. 2021;58:73–80. https://doi.org/10.1007/s00592-020-01594-6.CrossRefPubMed

60.

Goodpaster BH, Theriault R, Watkins SC, Kelley DE. Intramuscular lipid content is increased in obesity and decreased by weight loss. Metabolism. 2000;49:467–72. https://doi.org/10.1016/s0026-0495(00)80010-4.CrossRefPubMed

61.

Rolland Y, Lauwers-Cances V, Pahor M, Fillaux J, Grandjean H, Vellas B. Muscle strength in obese elderly women: effect of recreational physical activity in a cross-sectional study. Am J Clin Nutr. 2004;79:552–7. https://doi.org/10.1093/ajcn/79.4.552.CrossRefPubMed

62.

Goodpaster BH, Thaete FL, Kelley DE. Composition of skeletal muscle evaluated with computed tomography. Ann N Y Acad Sci. 2000;904:18–24. https://doi.org/10.1111/j.1749-6632.2000.tb06416.x.CrossRefPubMed

63.

Hamaguchi Y, Kaido T, Okumura S, Kobayashi A, Shirai H, Yao S, Yagi S, Kamo N, Seo S, Taura K, Okajima H, Uemoto S. Preoperative visceral adiposity and muscularity predict poor outcomes after hepatectomy for hepatocellular carcinoma. Liver Cancer. 2019;8:92–109. https://doi.org/10.1159/000488779.CrossRefPubMed

64.

Foster MC, Hwang SJ, Porter SA, Massaro JM, Hoffmann U, Fox CS. Fatty kidney, Hypertension, and chronic Kidney Disease: the Framingham Heart Study. Hypertension. 2011;58:784–90. https://doi.org/10.1161/HYPERTENSIONAHA.111.175315.CrossRefPubMed

65.

Miljkovic I, Vella CA, Allison M. Computed tomography-derived myosteatosis and metabolic disorders. Diabetes Metab J. 2021;45:482–91. https://doi.org/10.4093/dmj.2020.0277.CrossRefPubMedPubMedCentral

66.

Goodpaster BH, Kelley DE, Thaete FL, He J, Ross R. Skeletal muscle attenuation determined by computed tomography is associated with skeletal muscle lipid content. J Appl Physiol (1985). 2000;89:104–10. https://doi.org/10.1152/jappl.2000.89.1.104.CrossRefPubMed

67.

Huynh K, Ayers C, Butler J, Neeland I, Kritchevsky S, Pandey A, Barton G, Berry JD. Association between thigh muscle fat infiltration and incident Heart Failure: the health ABC study. JACC Heart Fail. 2022;10:485–93. https://doi.org/10.1016/j.jchf.2022.04.012.CrossRefPubMed

68.

Nachit M, Kwanten WJ, Thissen JP, Op De Beeck B, Van Gaal L, Vonghia L, Verrijken A, Driessen A, Horsmans Y, Francque S, Leclercq IA. Muscle fat content is strongly associated with NASH: a longitudinal study in patients with morbid obesity. J Hepatol. 2021;75:292–301. https://doi.org/10.1016/j.jhep.2021.02.037.CrossRefPubMed

69.

Rahemi H, Nigam N, Wakeling JM. The effect of intramuscular fat on skeletal muscle mechanics: implications for the elderly and obese. J R Soc Interface. 2015;12:20150365. https://doi.org/10.1098/rsif.2015.0365.CrossRefPubMedPubMedCentral

70.

Addison O, Drummond MJ, LaStayo PC, Dibble LE, Wende AR, McClain DA, Marcus RL. Intramuscular fat and inflammation differ in older adults: the impact of frailty and inactivity. J Nutr Health Aging. 2014;18:532–8. https://doi.org/10.1007/s12603-014-0019-1.CrossRefPubMedPubMedCentral

71.

Therkelsen KE, Pedley A, Hoffmann U, Fox CS, Murabito JM. Intramuscular fat and physical performance at the Framingham Heart Study. Age (Dordr). 2016;38:31. https://doi.org/10.1007/s11357-016-9893-2.CrossRefPubMed

72.

Kim MK, Kim W, Kwon HS, Baek KH, Kim EK, Song KH. Effects of bariatric Surgery on metabolic and nutritional parameters in severely obese Korean patients with type 2 Diabetes: a prospective 2-year follow up. J Diabetes Investig. 2014;5:221–7. https://doi.org/10.1111/jdi.12137.CrossRefPubMed

73.

Camastra S, Vitali A, Anselmino M, Gastaldelli A, Bellini R, Berta R, Severi I, Baldi S, Astiarraga B, Barbatelli G, Cinti S, Ferrannini E. Muscle and adipose tissue morphology, insulin sensitivity and beta-cell function in diabetic and nondiabetic obese patients: effects of bariatric Surgery. Sci Rep. 2017;7:9007. https://doi.org/10.1038/s41598-017-08444-6.CrossRefPubMedPubMedCentral

74.

Ma Q, Cheng X, Hou X, Yan Y, Zhao C, Yang Z. Influence of sleeve gastrectomy on skeletal muscular fat infiltration measured by MRI in patients with metabolic syndrome: preliminary results. Ann Nutr Metab. 2023;79:78–87. https://doi.org/10.1159/000527941.CrossRefPubMed

75.

Faria SL, Kelly E, Faria OP. Energy expenditure and weight regain in patients submitted to roux-en-Y gastric bypass. Obes Surg. 2009;19:856–9. https://doi.org/10.1007/s11695-009-9842-6.CrossRefPubMed

76.

Sjöström L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B, Dahlgren S, Larsson B, Narbro K, Sjöström CD, Sullivan M, Wedel H. Lifestyle, Diabetes, and cardiovascular risk factors 10 years after bariatric Surgery. N Engl J Med. 2004;351:2683–93. https://doi.org/10.1056/NEJMoa035622.CrossRefPubMed

77.

Petersen MC, Shulman GI. Mechanisms of insulin action and insulin resistance. Physiol Rev. 2018;98:2133–223. https://doi.org/10.1152/physrev.00063.2017.CrossRefPubMedPubMedCentral

78.

Yoshino M, Kayser BD, Yoshino J, Stein RI, Reeds D, Eagon JC, Eckhouse SR, Watrous JD, Jain M, Knight R, Schechtman K, Patterson BW, Klein S. Effects of Diet versus gastric bypass on metabolic function in Diabetes. N Engl J Med. 2020;383:721–32. https://doi.org/10.1056/NEJMoa2003697.CrossRefPubMedPubMedCentral

79.

Ha J, Kwon Y, Park S. Metabolomics in bariatric Surgery: towards identification of mechanisms and biomarkers of metabolic outcomes. Obes Surg. 2021;31:4564–74. https://doi.org/10.1007/s11695-021-05566-9.CrossRefPubMed

80.

Kristensen MD, Petersen SM, Møller KE, Lund MT, Hansen M, Hansen CN, Courraud J, Helge JW, Dela F, Prats C. Obesity leads to impairments in the morphology and organization of human skeletal muscle lipid droplets and mitochondrial networks, which are resolved with gastric bypass surgery-induced improvements in insulin sensitivity. Acta Physiol (Oxf). 2018;224:e13100. https://doi.org/10.1111/apha.13100.CrossRefPubMed

81.

Weigert C, Klopfer K, Kausch C, Brodbeck K, Stumvoll M, Häring HU, Schleicher ED. Palmitate-induced activation of the hexosamine pathway in human myotubes: increased expression of glutamine:fructose-6-phosphate aminotransferase. Diabetes. 2003;52:650–6. https://doi.org/10.2337/diabetes.52.3.650.CrossRefPubMed

82.

Cho MR, Lee S, Song SK. A review of Sarcopenia pathophysiology, diagnosis, treatment and future direction. J Korean Med Sci. 2022;37:e146. https://doi.org/10.3346/jkms.2022.37.e146.CrossRefPubMedPubMedCentral

83.

Lynch GS. Update on emerging Drugs for Sarcopenia - age-related muscle wasting. Expert Opin Emerg Drugs. 2008;13:655–73. https://doi.org/10.1517/14728210802544476.CrossRefPubMed

84.

Wagner KR, Fleckenstein JL, Amato AA, Barohn RJ, Bushby K, Escolar DM, Flanigan KM, Pestronk A, Tawil R, Wolfe GI, Eagle M, Florence JM, King WM, Pandya S, Straub V, Juneau P, Meyers K, Csimma C, Araujo T, Allen R, Parsons SA, Wozney JM, Lavallie ER, Mendell JR. A phase I/IItrial of MYO-029 in adult subjects with muscular dystrophy. Ann Neurol. 2008;63:561–71. https://doi.org/10.1002/ana.21338.CrossRefPubMed

85.

Andersson DC, Betzenhauser MJ, Reiken S, Meli AC, Umanskaya A, Xie W, Shiomi T, Zalk R, Lacampagne A, Marks AR. Ryanodine receptor oxidation causes intracellular calcium leak and muscle weakness in aging. Cell Metab. 2011;14:196–207. https://doi.org/10.1016/j.cmet.2011.05.014.CrossRefPubMedPubMedCentral

86.

Akazawa N, Harada K, Okawa N, Tamura K, Moriyama H. Muscle mass and intramuscular fat of the quadriceps are related to muscle strength in non-ambulatory chronic Stroke survivors: a cross-sectional study. PLoS ONE. 2018;13:e0201789. https://doi.org/10.1371/journal.pone.0201789.CrossRefPubMedPubMedCentral

87.

Baumgartner RN, Wayne SJ, Waters DL, Janssen I, Gallagher D, Morley JE. Sarcopenic obesity predicts instrumental activities of daily living disability in the elderly. Obes Res. 2004;12:1995–2004.CrossRefPubMed

88.

Baumgartner RN. Body composition in healthy aging. Ann N Y Acad Sci. 2000;904:437–48. https://doi.org/10.1111/j.1749-6632.2000.tb06498.x.CrossRefPubMed

Title: A multifaceted and inclusive methodology for the detection of sarcopenia in patients undergoing bariatric surgery: an in-depth analysis of current evidence
Authors: Eunhye Seo
Yeongkeun Kwon
Ahmad ALRomi
Mohannad Eledreesi
Sungsoo Park
Publication date: 01-03-2024
Publisher: Springer US
Keywords: Obesity
Bariatric Surgery
Sarcopenia
Esophagus and Gastrointestinal Tract
Published in: Reviews in Endocrine and Metabolic Disorders
Print ISSN: 1389-9155
Electronic ISSN: 1573-2606
DOI: https://doi.org/10.1007/s11154-023-09864-8

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

A multifaceted and inclusive methodology for the detection of sarcopenia in patients undergoing bariatric surgery: an in-depth analysis of current evidence

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page